NASDAQ:AFIB

Acutus Medical (AFIB) Stock Price, News & Analysis

Acutus Medical logo
$0.0001 0.00 (0.00%)
As of 11/20/2026 09:30 AM Eastern

About Acutus Medical Stock (NASDAQ:AFIB)

Advanced

Key Stats

Today's Range
$0.0001
▼
$0.0001
50-Day Range
N/A
52-Week Range
$0.0001
▼
$0.0140
Volume
2,500 shs
Average Volume
9,863 shs
Market Capitalization
$2.99 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Acutus Medical, Inc. was a medical technology company focused on tools for diagnosing and treating cardiac arrhythmias, including atrial fibrillation. Its products were designed for use in electrophysiology procedures, in which clinicians map the heart’s electrical activity and may use catheter ablation to treat abnormal rhythms.

The company’s offerings included the AcQMap 3D imaging and mapping system, which used ultrasound and electrical data to create maps of the heart, as well as related mapping and ablation catheters and accessories. Acutus marketed its products in the United States and international markets.

In 2024, Medtronic acquired substantially all of Acutus Medical’s assets, including its electrophysiology business. Acutus is therefore best understood as a former medical-device company whose technology and product portfolio became part of Medtronic’s electrophysiology business.

AI Generated. May Contain Errors.

Receive AFIB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acutus Medical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AFIB Stock News Headlines

AFIB Acutus Medical, Inc. - Seeking Alpha
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.tc pixel
Acutus Medical Reports Full Year 2024 Financial Results
Acutus Medical Announces Operational Downsizing
Acutus Medical Reports Q3 2024 Financial Results
See More Headlines

AFIB Stock Analysis - Frequently Asked Questions

Acutus Medical's stock was trading at $0.0002 on January 1st, 2026. Since then, AFIB stock has decreased by 50.0% and is now trading at $0.0001.

Acutus Medical, Inc. (NASDAQ:AFIB) announced its earnings results on Thursday, November, 11th. The company reported ($0.94) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.92) by $0.02. The company earned $4.60 million during the quarter, compared to analyst estimates of $6.02 million. Acutus Medical had a negative trailing twelve-month return on equity of 311.64% and a negative net margin of 272.74%.

Acutus Medical subsidiaries include Acutus Medical N.V..

Acutus Medical (AFIB) raised $126 million in an IPO on Thursday, August 6th 2020. The company issued 7,400,000 shares at $16.00-$18.00 per share. J.P. Morgan, BofA Securities and William Blair acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

Shares of AFIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Acutus Medical investors own include Walt Disney (DIS), Moderna (MRNA), NVIDIA (NVDA), Shopify (SHOP), AMC Entertainment (AMC), Alibaba Group (BABA) and Salesforce (CRM).

Company Calendar

Today
11/21/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:AFIB
CIK
1522860
Employees
85
Year Founded
2011

Profitability

EPS (Trailing Twelve Months)
($0.11)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$81.66 million
Net Margins
-272.74%
Pretax Margin
-30.32%
Return on Equity
-311.64%
Return on Assets
-11.57%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.85
Quick Ratio
1.57

Sales & Book Value

Annual Sales
$7.16 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.03) per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
29,912,000
Free Float
28,228,000
Market Cap
$2.99 thousand
Optionable
No Data
Beta
5.96

Social Links

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (NASDAQ:AFIB) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners